Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates

• click to rate

  Posted by Two Blokes May 5 - Filed in Stock - 0 views
  
  Castle Biosciences, Inc. (CSTL) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.09 per share a year ago.